세계의 정형외과 플래닝 시스템 시장 : 제품 유형별, 최종 사용자별, 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카)-산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Orthopedic Planning Systems Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

US $ 4,995 ￦ 6,828,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 9,972,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,613,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 정형외과 플래닝 시스템 시장을 철저히 분석하고 세계의 전망을 자세히 설명하는 종합적인 보고서를 제공합니다. 이 상세한 출판물은 시장 역학, 동향, 기회, 과제에 대한 귀중한 인사이트를 제공하고 구조의 종합적인 개요를 제공합니다. 독자적인 데이터와 통계에 뒷받침된 본 조사에서는 2024년부터 2031년까지의 정형외과 플래닝 시스템 시장 예측 성장 궤도를 예측했습니다.

2024년 세계 정형외과 플래닝 시스템의 수익은 8,615만 달러로 추정되고, CAGR 7.9%로 성장할 전망이며, 2031년에는 1억 5,820만 달러에 이를 것으로 예측됩니다.

주요 인사이트

• 정형외과 플래닝 시스템 시장 규모(2024년) : 8,615만 달러
• 예측 시장 가치(2031년) : 1억 5,820만 달러
• 세계 시장 성장률(CAGR 2024-2032년) : 7.9%

정형외과 플래닝 시스템 시장-조사 범위

세계의 정형외과 플래닝 시스템 시장은 정형외과 의사와 건강 관리 제공업체에게 다양한 솔루션을 제공하여 수술 계획 및 임플란트 선택을 용이하게 합니다. 주요 촉진요인은 의료 기술의 진보, 정형외과 질환의 유병률 증가, 고령화 인구 증가 등입니다. 새로운 동향으로는 맞춤형 의료 및 3D 프린팅 용도가 있습니다. 전반적으로 효율적인 수술에 대한 수요 증가, 환자 결과 개선, 비용 효율적인 건강 관리 솔루션에 대한 요구가 시장을 이끌고 있습니다.

시장 성장 촉진요인

정형외과 플래닝 시스템의 채용 확대는 기술 혁신과 저침습 외과 수술의 수용확대 등 상호 관련된 여러 요인에 의해 뒷받침되고 있습니다. 이미지 양식과 컴퓨터 지원 수술의 진보는 수술의 정확성과 환자의 안전성을 높이고 정형외과 계획 솔루션 수요를 촉진합니다. 또한 고령화와 비만률의 상승과 같은 인구동태의 변화도 정형외과 질환의 이환율 상승에 기여하고 있어 시장의 성장을 뒷받침하고 있습니다. 의료 서비스 제공업체는 치료 결과를 최적화하고 합병증을 최소화하기 위해 노력하고 있으며, 정형외과 플래닝 시스템은 수술의 간소화와 환자 관리의 강화에 중요한 역할을 수행합니다.

시장 성장 억제요인

정형외과 플래닝 시스템 시장이 직면한 과제로는 규제상의 장애물, 상환제한, 데이터 보안 우려 등이 있습니다. 의료기기 및 소프트웨어에 대한 엄격한 규제 요건을 준수하는 것은 시장 진출기업에게 어려움이 있으며, 연구 개발 및 규제 준수를 위해 많은 투자가 필요합니다. 또한, 상환 정책은 지역마다 다르므로 정형외과 치료 계획 시스템의 도입과 의료 제공업체의 의사결정에 영향을 미칩니다. 데이터 보안 및 환자 프라이버시에 대한 우려도 시장 성장의 장벽이 되고 있으며, 환자 정보를 보호하기 위해 견고한 사이버 보안 대책과 데이터 보호 규정을 준수해야 합니다.

시장 기회

정형외과 플래닝 시스템 분야 시장 성장 기회에는 신흥 시장에서의 용도 확대, 기술 진보, 전략적 파트너십 등이 있습니다. 신흥국에서는 정형외과 질환의 유병률이 상승하고 있어 헬스케어 인프라가 개선되어 진보된 의료기술에 대한 접근이 증가하기 때문에 시장 확대의 기회가 탄생하고 있습니다. 또한, 현재 진행 중인 3D 프린팅 및 인공지능 기술 혁신은 정형외과 플래닝 시스템의 기능을 강화할 수 있는 기회를 제공하여 맞춤 치료 접근법과 수술 결과를 최적화할 수 있습니다. 정형외과 장비 제조업체, 소프트웨어 개발자 및 의료 기관의 협업은 정형외과 의사와 환자의 진화하는 요구에 대응하는 통합 솔루션의 개발을 촉진합니다.

보고서가 답변하는 주요 질문

• 정형외과 플래닝 시스템 시장의 성장을 가속하는 주요 요인은 무엇인가?
• 정형외과 플래닝 시스템 시장을 형성하는 새로운 동향은 무엇인가?
• 시장 확대를 저해하는 주요 과제는 무엇이며 어떻게 완화될 수 있는가?
• 정형외과 플래닝 시스템 분야에서 시장 진출기업이 활용할 수 있는 기회에는 무엇이 있는가?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위 및 분류
• 시장의 정의, 범위 및 제한
• 포함 및 제외

제3장 주요 시장 동향

• 시장에 영향을 주는 주요 동향
• 제품 혁신 및 개발 동향

제4장 시장 배경

• 거시경제 요인
• 예측 요인
• 시장 역학
• 세계 수급 분석

제5장 COVID19의 위기 분석

• COVID19의 현재 통계 및 미래의 영향 가능성
• COVID19와 영향 분석
  • 솔루션별
  • 용도별
  • 전개별
  • 최종 사용자별

제6장 주요 성공 요인

• 주요 발전
• 규제 시나리오
• 주요 거래 및 계약
• 지역별 수술 건수

제7장 세계의 정형외과 플래닝 시스템 시장 : 가격 분석

• 국가별 및 지역별 가격 분석(솔루션별)
• 가격 분석
  • 제조업체 레벨의 가격 설정
  • 유통업체 레벨의 가격 설정
• 세계 평균 가격 분석 벤치마크

제8장 세계의 정형외과 플래닝 시스템 시장 수요 분석(2019-2023년) 및 예측(2024-2031년)

• 과거 시장 매출 분석(2019-2023년)
• 현재 및 장래 시장 매출 예측(2024-2031년)
  • 전년대비 성장 동향 분석
  • 절대적 이익의 기회 분석

제9장 세계의 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년) : 솔루션별

• 서문 : 주요 조사 결과
• 과거 시장 규모 분석 : 솔루션별(2019-2023년)
• 현재 및 미래 시장 규모 분석 및 예측 : 솔루션별(2024-2031년)
  • 정형외과 플래닝 시스템
    • 수술 전 계획 소프트웨어
      • 2D플래닝 소프트웨어
      • 3D플래닝 소프트웨어
    • 수술 후 계획 소프트웨어
• 시장 매력 분석 : 솔루션별

제10장 세계의 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년) : 용도별

• 서문 : 주요 조사 결과
• 과거 시장 규모 분석 : 용도별(2019-2023년)
• 현재 및 장래 시장 규모의 분석 및 예측 : 용도별(2024-2031년)
  • 정형외과
    • 관절 치환술
      • 고관절 치환술
      • 무릎 관절 치환술
      • 어깨 관절 치환술
      • 소골 치환
  • 정형외과 종양학
• 시장 매력 분석 : 용도별

제11장 세계의 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년) : 전개별

• 서문 : 주요 조사 결과
• 과거 시장 규모 분석 : 전개별(2019-2023년)
• 현재 및 장래 시장 규모의 분석 및 예측 : 전개별(2024-2031년)
  • 웹 기반 소프트웨어
  • 클라우드 기반 소프트웨어
  • 온프레미스
• 시장 매력 분석 : 전개별

제12장 세계의 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년) : 최종 사용자별

• 서문 : 주요 조사 결과
• 과거 시장 규모 분석 : 최종 사용자별(2019-2023년)
• 현재 및 장래 시장 규모의 분석 및 예측 : 최종 사용자별(2024-2031년)
  • 병원
  • 외래수술센터(ASC)
  • 정형외과 진료소 베이스
  • 클리닉
• 시장 매력 분석 : 최종 사용자별

제13장 세계의 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년) : 지역별

• 서문
• 과거 시장 규모 분석 : 지역별(2019-2023년)
• 현재 시장 규모 분석 및 예측 : 지역별(2024-2031년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 시장 매력 분석 : 지역별

제14장 북미의 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년)

제15장 라틴아메리카의 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년)

제16장 유럽 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년)

제17장 남아시아 및 태평양 지역의 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년)

제18장 동아시아의 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년)

제19장 오세아니아 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년)

제20장 중동 및 아프리카의 정형외과 플래닝 시스템 시장 분석(2019-2023년) 및 예측(2024-2031년)

제21장 주요 국가별 정형외과 플래닝 시스템 시장 분석(2024-2031년)

• 서문
  • 시장 매출 비율 분석
  • 세계 및 국가별 성장 비교
  • 국가별 가격 분석
• 미국
• 캐나다
• 멕시코
• 브라질
• 독일
• 이탈리아
• 프랑스
• 영국
• 스페인
• 러시아
• 중국
• 일본
• 한국
• 인도
• ASEAN
• 호주
• 뉴질랜드
• 터키
• 남아프리카

제22장 시장 구조 분석

• 시장 분석 : 기업 계층별(정형외과 플래닝 시스템)
• 주요 기업의 시장 점유율 분석
• 시장 현재 분석

제23장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁의 상세 정보
  • Formus Labs Ltd
  • EOS imaging
  • Brainlab AG
  • Sectra AB
  • Stryker
  • Materialise
  • Medstrat
  • MediCAD Hectec GmbH
  • 3D Systems, Inc
  • PEEK HEALTH SA
  • Radlink, Inc.
  • SurgiNovi
  • RSA Biomedical
  • HIPOP-PLAN
  • Zimmer Biomet.
  • Optinav
  • Enhatch Inc.
  • Numex GmbH
  • Corin Group

제24장 전제 조건 및 사용되는 약어

제25장 조사 방법

AJY

영문 목차

영문목차

Persistence Market Research has conducted a thorough analysis of the Orthopedic Planning Systems Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Orthopedic Planning Systems Market spanning from 2024 to 2031.

In 2024, global revenue from orthopedic planning systems reached US$ 86.15 million, projected to grow at a CAGR of 7.9%, reaching US$ 158.2 million by 2031.

Key Insights:

• Orthopedic Planning Systems Market Size (2024): US$ 86.15 Mn
• Projected Market Value (2031): US$ 158.2 Mn
• Global Market Growth Rate (2024-2031): 7.9% CAGR

Orthopedic Planning Systems Market - Report Scope

The global orthopedic planning systems market offers various solutions for orthopedic surgeons and healthcare providers, facilitating surgical planning and implant selection. Key drivers include advancements in medical technology, increasing prevalence of orthopedic disorders, and the growing aging population. Emerging trends focus on personalized medicine and 3D printing applications. Overall, the market is driven by the rising demand for efficient surgical procedures, improved patient outcomes, and the need for cost-effective healthcare solutions.

Market Growth Drivers

The expanding adoption of orthopedic planning systems is fueled by several interconnected factors, including technological innovation and the growing acceptance of minimally invasive surgical techniques. Advances in imaging modalities and computer-assisted surgery enhance surgical accuracy and patient safety, driving the demand for orthopedic planning solutions. Additionally, demographic shifts, such as an aging population and rising obesity rates, contribute to the increasing incidence of orthopedic conditions, boosting market growth. As healthcare providers strive to optimize treatment outcomes and minimize complications, orthopedic planning systems play a crucial role in streamlining surgical procedures and enhancing patient care.

Market Restraints

Challenges facing the orthopedic planning systems market include regulatory hurdles, reimbursement limitations, and data security concerns. Compliance with stringent regulatory requirements for medical devices and software poses challenges for market players, necessitating substantial investments in research and development and regulatory compliance efforts. Moreover, reimbursement policies vary across regions, impacting the adoption of orthopedic planning systems and healthcare provider decisions. Data security and patient privacy concerns also present barriers to market growth, requiring robust cybersecurity measures and compliance with data protection regulations to safeguard patient information.

Opportunities

Opportunities for market growth in the orthopedic planning systems segment include expanding applications in emerging markets, technological advancements, and strategic partnerships. The rising prevalence of orthopedic disorders in developing countries creates opportunities for market expansion, as healthcare infrastructure improves and access to advanced medical technologies increases. Furthermore, ongoing innovations in 3D printing and artificial intelligence offer opportunities to enhance the capabilities of orthopedic planning systems, enabling personalized treatment approaches and optimizing surgical outcomes. Collaborations between orthopedic device manufacturers, software developers, and healthcare institutions facilitate the development of integrated solutions that address the evolving needs of orthopedic surgeons and patients.

Key Questions Answered in Report::

• What are the key drivers propelling the growth of the orthopedic planning systems market?
• What emerging trends are shaping the landscape of orthopedic planning systems?
• What are the primary challenges hindering market expansion, and how can they be mitigated?
• What opportunities exist for market players to capitalize on in the orthopedic planning systems segment?

Competitive Intelligence and Business Strategy

In October 2020, EOS imaging installed its first EOSedge(TM) system at the Macquarie University Hospital in Australia, marking a significant milestone for the company in expanding its market presence.

In December 2020, Zimmer Biomet bolstered its product offerings by acquiring A&E Medical, gaining access to a diverse portfolio of sternal closure devices, including cable systems and sternal sutures.

In April 2020, Brainlab achieved CE Mark approval for its advanced patient positioning and monitoring system, ExacTrac(R) Dynamic, demonstrating its commitment to innovation and meeting regulatory standards.

Key Companies Profiled

• Formus Labs Ltd,
• EOS imaging,
• Brainlab AG,
• Sectra AB,
• Stryker,
• Materialise,
• Medstrat,
• mediCAD Hectec GmbH,
• 3D Systems, Inc.,
• PEEK HEALTH S.A,
• Radlink, Inc.,
• SurgiNovi,
• RSA Biomedical,
• HIPOP-PLAN,
• Zimmer Biomet,
• Optinav,
• Enhatch Inc.,

Key Segments Covered in Orthopedic Planning Systems Industry Research

Orthopedic Planning Systems Market by Solution:

• Pre-Surgical Planning Software

o2D Planning Software

o3D Planning Software

• Post-Surgical Planning Software

Orthopedic Planning Systems Market by Application:

• Joint Replacement

oHip Replacement

oKnee Replacement

oShoulder Replacement

oSmall Bone Replacement

• Orthopaedic Oncology

Orthopedic Planning Systems Market by Deployment:

• Web Based Software
• Cloud Based Software
• On Premises

Orthopedic Planning Systems Market by End User:

• Hospitals
• Ambulatory Surgical Centers
• Orthopaedic Office-Based Clinics

Orthopedic Planning Systems Market by Region:

• North America Orthopedic Planning Systems Market
• Latin America Orthopedic Planning Systems Market
• Europe Orthopedic Planning Systems Market
• South Asia Orthopedic Planning Systems Market
• East Asia Orthopedic Planning Systems Market
• Oceania Orthopedic Planning Systems Market
• Middle East & Africa Orthopedic Planning Systems Market

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Market Background

• 4.1. Macro-Economic factors
  • 4.1.1. Global Healthcare Market Outlook
  • 4.1.2. Healthcare IT Spending Outlook, By U.S. & Global
  • 4.1.3. U.S. per-Capita Healthcare Expenditure
• 4.2. Forecast Factors
  • 4.2.1. Evaluation of Incremental Costs and Effectiveness
  • 4.2.2. Increasing Spending on Healthcare Per Capita
  • 4.2.3. Increasing Spending for Healthcare Infrastructure Development Post COVID-19 Pandemic
  • 4.2.4. Application of biomedical and nanotechnology in Orthopaedics
• 4.3. Market Dynamics
  • 4.3.1. Demand
  • 4.3.2. Restraints
  • 4.3.3. Opportunity
• 4.4. Global Supply Demand Analysis

5. COVID19 Crisis Analysis

• 5.1. Current COVID19 Statistics and Probable Future Impact
• 5.2. COVID19 and Impact Analysis
  • 5.2.1. By Solution
  • 5.2.2. By Application
  • 5.2.3. By Deployment
  • 5.2.4. By End User

6. Key Success Factors

• 6.1. Key Developments
• 6.2. Regulatory Scenario
• 6.3. Key Deals and Contracts
• 6.4. Number of Surgeries, By Region

7. Global Orthopedic Planning Systems Market - Pricing Analysis

• 7.1. Country-wise & Regional Pricing Analysis, By Solution
• 7.2. Pricing Break-up
  • 7.2.1. Manufacturer Level Pricing
  • 7.2.2. Distributor Level Pricing
• 7.3. Global Average Pricing Analysis Benchmark

8. Global Orthopedic Planning Systems Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

• 8.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 8.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
  • 8.2.1. Y-o-Y Growth Trend Analysis
  • 8.2.2. Absolute $ Opportunity Analysis

9. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Solution

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis, By Solution, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Solution, 2024-2031
  • 9.3.1. Orthopedic Planning Systems
    • 9.3.1.1. Pre-Surgical Planning Software
      • 9.3.1.1.1. 2D Planning Software
      • 9.3.1.1.2. 3D Planning Software
    • 9.3.1.2. Post-Surgical Planning Software
• 9.4. Market Attractiveness Analysis, By Solution

10. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Application

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 10.3.1. Orthopedic Surgery
    • 10.3.1.1. Joint Replacement
      • 10.3.1.1.1. Hip Replacement
      • 10.3.1.1.2. Knee Replacement
      • 10.3.1.1.3. Shoulder Replacement
      • 10.3.1.1.4. Small Bone Replacement
  • 10.3.2. Orthopedic Oncology
• 10.4. Market Attractiveness Analysis, By Application

11. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Deployment

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis, By Deployment, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Deployment, 2024-2031
  • 11.3.1. Web Based Software
  • 11.3.2. Cloud Based Software
  • 11.3.3. On Premises
• 11.4. Market Attractiveness Analysis, By Deployment

12. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
  • 12.3.1. Hospitals
  • 12.3.2. Ambulatory Surgical Centres
  • 12.3.3. Orthopedic Office-Based
  • 12.3.4. Clinics
• 12.4. Market Attractiveness Analysis, By End User

13. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
• 13.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. East Asia
  • 13.3.5. South Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa (MEA)
• 13.4. Market Attractiveness Analysis, By Region

14. North America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 14.1. Introduction
• 14.2. Pricing Analysis
• 14.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 14.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 14.4.1. By Country
    • 14.4.1.1. U.S.
    • 14.4.1.2. Canada
  • 14.4.2. By Solution
  • 14.4.3. By Application
  • 14.4.4. By Deployment
  • 14.4.5. By End User
• 14.5. Market Attractiveness Analysis
  • 14.5.1. By Country
  • 14.5.2. By Solution
  • 14.5.3. By Application
  • 14.5.4. By Deployment
  • 14.5.5. By End User
• 14.6. Market Trends
• 14.7. Key Market Participants - Intensity Mapping
• 14.8. Drivers and Restraints - Impact Analysis

15. Latin America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 15.1. Introduction
• 15.2. Pricing Analysis
• 15.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 15.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 15.4.1. By Country
    • 15.4.1.1. Brazil
    • 15.4.1.2. Mexico
    • 15.4.1.3. Rest of Latin America
  • 15.4.2. By Solution
  • 15.4.3. By Application
  • 15.4.4. By Deployment
  • 15.4.5. By End User
• 15.5. Market Attractiveness Analysis
  • 15.5.1. By Country
  • 15.5.2. By Solution
  • 15.5.3. By Application
  • 15.5.4. By Deployment
  • 15.5.5. By End User
• 15.6. Market Trends
• 15.7. Key Market Participants - Intensity Mapping
• 15.8. Drivers and Restraints - Impact Analysis

16. Europe Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 16.1. Introduction
• 16.2. Pricing Analysis
• 16.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 16.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 16.4.1. By Country
    • 16.4.1.1. Germany
    • 16.4.1.2. Italy
    • 16.4.1.3. France
    • 16.4.1.4. U.K.
    • 16.4.1.5. Spain
    • 16.4.1.6. BENELUX
    • 16.4.1.7. Russia
    • 16.4.1.8. Rest of Europe
  • 16.4.2. By Solution
  • 16.4.3. By Application
  • 16.4.4. By Deployment
  • 16.4.5. By End User
• 16.5. Market Attractiveness Analysis
  • 16.5.1. By Country
  • 16.5.2. By Solution
  • 16.5.3. By Application
  • 16.5.4. By Deployment
  • 16.5.5. By End User
• 16.6. Market Trends
• 16.7. Key Market Participants - Intensity Mapping
• 16.8. Drivers and Restraints - Impact Analysis

17. South Asia and Pacific Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 17.1. Introduction
• 17.2. Pricing Analysis
• 17.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 17.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 17.4.1. By Country
    • 17.4.1.1. India
    • 17.4.1.2. ASEAN
    • 17.4.1.3. Oceania
    • 17.4.1.4. Rest of South Asia & Pacific
  • 17.4.2. By Solution
  • 17.4.3. By Application
  • 17.4.4. By Deployment
  • 17.4.5. By End User
• 17.5. Market Attractiveness Analysis
  • 17.5.1. By Country
  • 17.5.2. By Solution
  • 17.5.3. By Application
  • 17.5.4. By Deployment
  • 17.5.5. By End User
• 17.6. Market Trends
• 17.7. Key Market Participants - Intensity Mapping
• 17.8. Drivers and Restraints - Impact Analysis

18. East Asia Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 18.1. Introduction
• 18.2. Pricing Analysis
• 18.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 18.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 18.4.1. By Country
    • 18.4.1.1. China
    • 18.4.1.2. Japan
    • 18.4.1.3. South Korea
  • 18.4.2. By Solution
  • 18.4.3. By Application
  • 18.4.4. By Deployment
  • 18.4.5. By End User
• 18.5. Market Attractiveness Analysis
  • 18.5.1. By Country
  • 18.5.2. By Solution
  • 18.5.3. By Application
  • 18.5.4. By Deployment
  • 18.5.5. By End User
• 18.6. Market Trends
• 18.7. Key Market Participants - Intensity Mapping
• 18.8. Drivers and Restraints - Impact Analysis

19. Oceania Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 19.1. Introduction
• 19.2. Pricing Analysis
• 19.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 19.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 19.4.1. By Country
    • 19.4.1.1. Australia
    • 19.4.1.2. New Zealand
  • 19.4.2. By Solution
  • 19.4.3. By Application
  • 19.4.4. By Deployment
  • 19.4.5. By End User
• 19.5. Market Attractiveness Analysis
  • 19.5.1. By Country
  • 19.5.2. By Solution
  • 19.5.3. By Application
  • 19.5.4. By Deployment
  • 19.5.5. By End User
• 19.6. Market Trends
• 19.7. Key Market Participants - Intensity Mapping
• 19.8. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

• 20.1. Introduction
• 20.2. Pricing Analysis
• 20.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
• 20.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
  • 20.4.1. By Country
    • 20.4.1.1. GCC Countries
    • 20.4.1.2. Turkey
    • 20.4.1.3. Northern Africa
    • 20.4.1.4. South Africa
    • 20.4.1.5. Rest of Middle East and Africa
  • 20.4.2. By Solution
  • 20.4.3. By Application
  • 20.4.4. By Deployment
  • 20.4.5. By End User
• 20.5. Market Attractiveness Analysis
  • 20.5.1. By Country
  • 20.5.2. By Solution
  • 20.5.3. By Application
  • 20.5.4. By Deployment
  • 20.5.5. By End User
• 20.6. Market Trends
• 20.7. Key Market Participants - Intensity Mapping
• 20.8. Drivers and Restraints - Impact Analysis

21. Country Level Orthopedic Planning Systems Market Analysis 2024-2031

• 21.1. Introduction
  • 21.1.1. Market Value Proportion Analysis
  • 21.1.2. Global VS. Country Growth Comparison
  • 21.1.3. Pricing Analysis, by Country
• 21.2. U.S. Orthopedic Planning Systems Market Analysis
  • 21.2.1. By Solution
  • 21.2.2. By Application
  • 21.2.3. By Deployment
  • 21.2.4. By End User
• 21.3. Canada Orthopedic Planning Systems Market Analysis
  • 21.3.1. By Solution
  • 21.3.2. By Application
  • 21.3.3. By Deployment
  • 21.3.4. By End User
• 21.4. Mexico Orthopedic Planning Systems Market Analysis
  • 21.4.1. By Solution
  • 21.4.2. By Application
  • 21.4.3. By Deployment
  • 21.4.4. By End User
• 21.5. Brazil Orthopedic Planning Systems Market Analysis
  • 21.5.1. By Solution
  • 21.5.2. By Application
  • 21.5.3. By Deployment
  • 21.5.4. By End User
• 21.6. Germany Orthopedic Planning Systems Market Analysis
  • 21.6.1. By Solution
  • 21.6.2. By Application
  • 21.6.3. By Deployment
  • 21.6.4. By End User
• 21.7. Italy Orthopedic Planning Systems Market Analysis
  • 21.7.1. By Solution
  • 21.7.2. By Application
  • 21.7.3. By Deployment
  • 21.7.4. By End User
• 21.8. France Orthopedic Planning Systems Market Analysis
  • 21.8.1. By Solution
  • 21.8.2. By Application
  • 21.8.3. By Deployment
  • 21.8.4. By End User
• 21.9. U.K. Orthopedic Planning Systems Market Analysis
  • 21.9.1. By Solution
  • 21.9.2. By Application
  • 21.9.3. By Deployment
  • 21.9.4. By End User
• 21.10. Spain Orthopedic Planning Systems Market Analysis
  • 21.10.1. By Solution
  • 21.10.2. By Application
  • 21.10.3. By Deployment
  • 21.10.4. By End User
• 21.11. Russia Orthopedic Planning Systems Market Analysis
  • 21.11.1. By Solution
  • 21.11.2. By Application
  • 21.11.3. By Deployment
  • 21.11.4. By End User
• 21.12. China Orthopedic Planning Systems Market Analysis
  • 21.12.1. By Solution
  • 21.12.2. By Application
  • 21.12.3. By Deployment
  • 21.12.4. By End User
• 21.13. Japan Orthopedic Planning Systems Market Analysis
  • 21.13.1. By Solution
  • 21.13.2. By Application
  • 21.13.3. By Deployment
  • 21.13.4. By End User
• 21.14. S. Korea Orthopedic Planning Systems Market Analysis
  • 21.14.1. By Solution
  • 21.14.2. By Application
  • 21.14.3. By Deployment
  • 21.14.4. By End User
• 21.15. India Orthopedic Planning Systems Market Analysis
  • 21.15.1. By Solution
  • 21.15.2. By Application
  • 21.15.3. By Deployment
  • 21.15.4. By End User
• 21.16. ASEAN Orthopedic Planning Systems Market Analysis
  • 21.16.1. By Solution
  • 21.16.2. By Application
  • 21.16.3. By Deployment
  • 21.16.4. By End User
• 21.17. Australia Orthopedic Planning Systems Market Analysis
  • 21.17.1. By Solution
  • 21.17.2. By Application
  • 21.17.3. By Deployment
  • 21.17.4. By End User
• 21.18. New Zealand Orthopedic Planning Systems Market Analysis
  • 21.18.1. By Solution
  • 21.18.2. By Application
  • 21.18.3. By Deployment
  • 21.18.4. By End User
• 21.19. Turkey Orthopedic Planning Systems Market Analysis
  • 21.19.1. By Solution
  • 21.19.2. By Application
  • 21.19.3. By Deployment
  • 21.19.4. By End User
• 21.20. South Africa Orthopedic Planning Systems Market Analysis
  • 21.20.1. By Solution
  • 21.20.2. By Application
  • 21.20.3. By Deployment
  • 21.20.4. By End User

22. Market Structure Analysis

• 22.1. Market Analysis, By Tier of Companies (Orthopedic Planning Systems)
• 22.2. Market Share Analysis of Top Players
• 22.3. Market Presence Analysis
  • 22.3.1. By Regional footprint of Players
  • 22.3.2. Device foot print by Players
  • 22.3.3. Channel Foot Print by Players

23. Competition Analysis

• 23.1. Competition Dashboard
• 23.2. Competition Benchmarking
• 23.3. Competition Deep Dive
  • 23.3.1. Formus Labs Ltd
    • 23.3.1.1. Overview & Key financials
    • 23.3.1.2. Product Portfolio
    • 23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.1.4. SWOT Analysis
    • 23.3.1.5. Sales Footprint
    • 23.3.1.6. Strategy Overview
    • 23.3.1.7. Sales and Marketing strategies
    • 23.3.1.8. Channel Strategies
  • 23.3.2. EOS imaging
    • 23.3.2.1. Overview & Key financials
    • 23.3.2.2. Product Portfolio
    • 23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.2.4. SWOT Analysis
    • 23.3.2.5. Sales Footprint
    • 23.3.2.6. Strategy Overview
    • 23.3.2.7. Sales and Marketing strategies
    • 23.3.2.8. Channel Strategies
  • 23.3.3. Brainlab AG
    • 23.3.3.1. Overview & Key financials
    • 23.3.3.2. Product Portfolio
    • 23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.3.4. SWOT Analysis
    • 23.3.3.5. Sales Footprint
    • 23.3.3.6. Strategy Overview
    • 23.3.3.7. Sales and Marketing strategies
    • 23.3.3.8. Channel Strategies
  • 23.3.4. Sectra AB
    • 23.3.4.1. Overview & Key financials
    • 23.3.4.2. Product Portfolio
    • 23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.4.4. SWOT Analysis
    • 23.3.4.5. Sales Footprint
    • 23.3.4.6. Strategy Overview
    • 23.3.4.7. Sales and Marketing strategies
    • 23.3.4.8. Channel Strategies
  • 23.3.5. Stryker
    • 23.3.5.1. Overview & Key financials
    • 23.3.5.2. Product Portfolio
    • 23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.5.4. SWOT Analysis
    • 23.3.5.5. Sales Footprint
    • 23.3.5.6. Strategy Overview
    • 23.3.5.7. Sales and Marketing strategies
    • 23.3.5.8. Channel Strategies
  • 23.3.6. Materialise
    • 23.3.6.1. Overview & Key financials
    • 23.3.6.2. Product Portfolio
    • 23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.6.4. SWOT Analysis
    • 23.3.6.5. Sales Footprint
    • 23.3.6.6. Strategy Overview
    • 23.3.6.7. Sales and Marketing strategies
    • 23.3.6.8. Channel Strategies
  • 23.3.7. Medstrat
    • 23.3.7.1. Overview & Key financials
    • 23.3.7.2. Product Portfolio
    • 23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.7.4. SWOT Analysis
    • 23.3.7.5. Sales Footprint
    • 23.3.7.6. Strategy Overview
    • 23.3.7.7. Sales and Marketing strategies
    • 23.3.7.8. Channel Strategies
  • 23.3.8. MediCAD Hectec GmbH
    • 23.3.8.1. Overview & Key financials
    • 23.3.8.2. Product Portfolio
    • 23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.8.4. SWOT Analysis
    • 23.3.8.5. Sales Footprint
    • 23.3.8.6. Strategy Overview
    • 23.3.8.7. Sales and Marketing strategies
    • 23.3.8.8. Channel Strategies
  • 23.3.9. 3D Systems, Inc
    • 23.3.9.1. Overview & Key financials
    • 23.3.9.2. Product Portfolio
    • 23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.9.4. SWOT Analysis
    • 23.3.9.5. Sales Footprint
    • 23.3.9.6. Strategy Overview
    • 23.3.9.7. Sales and Marketing strategies
    • 23.3.9.8. Channel Strategies
  • 23.3.10. PEEK HEALTH S.A
    • 23.3.10.1. Overview & Key financials
    • 23.3.10.2. Product Portfolio
    • 23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.10.4. SWOT Analysis
    • 23.3.10.5. Sales Footprint
    • 23.3.10.6. Strategy Overview
    • 23.3.10.7. Sales and Marketing strategies
    • 23.3.10.8. Channel Strategies
  • 23.3.11. Radlink, Inc.
    • 23.3.11.1. Overview & Key financials
    • 23.3.11.2. Product Portfolio
    • 23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.11.4. SWOT Analysis
    • 23.3.11.5. Sales Footprint
    • 23.3.11.6. Strategy Overview
    • 23.3.11.7. Sales and Marketing strategies
    • 23.3.11.8. Channel Strategies
  • 23.3.12. SurgiNovi
    • 23.3.12.1. Overview & Key financials
    • 23.3.12.2. Product Portfolio
    • 23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.12.4. SWOT Analysis
    • 23.3.12.5. Sales Footprint
    • 23.3.12.6. Strategy Overview
    • 23.3.12.7. Sales and Marketing strategies
    • 23.3.12.8. Channel Strategies
  • 23.3.13. RSA Biomedical
    • 23.3.13.1. Overview & Key financials
    • 23.3.13.2. Product Portfolio
    • 23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.13.4. SWOT Analysis
    • 23.3.13.5. Sales Footprint
    • 23.3.13.6. Strategy Overview
    • 23.3.13.7. Sales and Marketing strategies
    • 23.3.13.8. Channel Strategies
  • 23.3.14. HIPOP-PLAN
    • 23.3.14.1. Overview & Key financials
    • 23.3.14.2. Product Portfolio
    • 23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.14.4. SWOT Analysis
    • 23.3.14.5. Sales Footprint
    • 23.3.14.6. Strategy Overview
    • 23.3.14.7. Sales and Marketing strategies
    • 23.3.14.8. Channel Strategies
  • 23.3.15. Zimmer Biomet.
    • 23.3.15.1. Overview & Key financials
    • 23.3.15.2. Product Portfolio
    • 23.3.15.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.15.4. SWOT Analysis
    • 23.3.15.5. Sales Footprint
    • 23.3.15.6. Strategy Overview
    • 23.3.15.7. Sales and Marketing strategies
    • 23.3.15.8. Channel Strategies
  • 23.3.16. Optinav
    • 23.3.16.1. Overview & Key financials
    • 23.3.16.2. Product Portfolio
    • 23.3.16.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.16.4. SWOT Analysis
    • 23.3.16.5. Sales Footprint
    • 23.3.16.6. Strategy Overview
    • 23.3.16.7. Sales and Marketing strategies
    • 23.3.16.8. Channel Strategies
  • 23.3.17. Enhatch Inc.
    • 23.3.17.1. Overview & Key financials
    • 23.3.17.2. Product Portfolio
    • 23.3.17.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.17.4. SWOT Analysis
    • 23.3.17.5. Sales Footprint
    • 23.3.17.6. Strategy Overview
    • 23.3.17.7. Sales and Marketing strategies
    • 23.3.17.8. Channel Strategies
  • 23.3.18. Numex GmbH
    • 23.3.18.1. Overview & Key financials
    • 23.3.18.2. Product Portfolio
    • 23.3.18.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.18.4. SWOT Analysis
    • 23.3.18.5. Sales Footprint
    • 23.3.18.6. Strategy Overview
    • 23.3.18.7. Sales and Marketing strategies
    • 23.3.18.8. Channel Strategies
  • 23.3.19. Corin Group
    • 23.3.19.1. Overview & Key financials
    • 23.3.19.2. Product Portfolio
    • 23.3.19.3. Profitability by Market Segments (Product/Channel/Region)
    • 23.3.19.4. SWOT Analysis
    • 23.3.19.5. Sales Footprint
    • 23.3.19.6. Strategy Overview
    • 23.3.19.7. Sales and Marketing strategies
    • 23.3.19.8. Channel Strategies

24. Assumptions and Acronyms Used

25. Research Methodology

관련자료